Use of Drugs Associated with QT Interval Prolongation at the Hospital Level during the COVID-19 Pandemic in Colombia.
Andrés Gaviria-MendozaManuel Enrique Machado-DuqueLuis Fernando Valladales-RestrepoCarlos Fernando Tovar-YepesJorge Enrique Machado-AlbaPublished in: International journal of vascular medicine (2022)
The high proportion of patients treated at the hospital level who receive drugs with risk of prolonging the QT interval should alert those responsible for their care to avoid fatal outcomes, especially during the COVID-19 epidemic, when some QT drugs are being used more frequently.